No Data
No Data
BofA Securities Maintains DexCom(DXCM.US) With Buy Rating, Maintains Target Price $105
Dexcom's Strategic Advancements and Market Opportunities Justify Buy Rating With $105 Price Objective
Should We Be Delighted With DexCom, Inc.'s (NASDAQ:DXCM) ROE Of 24%?
The Zacks Analyst Blog Highlights Sprouts Farmers Market, DexCom, Hims & Hers Health, United Natural Foods and GoodRx
Dexcom Announces Promotion of Jake Leach to the Expanded Role of President and COO
Dexcom Announces Promotion Of Jake Leach To The Expanded Role Of President And COO >DXCM